Will the public take a universal influenza vaccine?: the need for social and behavioral science research

ABSTRACT

Every influenza season, uptake of the flu vaccine falls short of the Healthy People 2020 goal of at least 70% of adults being vaccinated. Mixed methods research finds multiple factors associated with this phenomenon including misconceptions about the vaccine, skepticism about an annual vaccine, concerns about efficacy and safety, lack of knowledge, perceived risk, among others. The national goal to develop, test and produce an effective universal influenza vaccine requires a significant scientific and financial investment in research. However, there is no true investment in the social and behavioral science research necessary to ensure that once a universal vaccine is available, the public will take that new vaccine. This article highlights some qualitative and quantitative research results to provide some understanding of the challenges to increasing vaccine uptake. We also identify research questions necessary to ensure adoption of new universal vaccines.

KEYWORDS:

• Universal influenza vaccine
• vaccine hesitancy
• vaccine acceptance
• perceived risk
• trust
• patient-provider communication

Disclosure of potential conflicts of interest

No potential conflict of interest was reported by the authors

Additional information

Funding

This study was funded by the Center of Excellence in Race, Ethnicity and Health Disparities Research [NIH-NIMHD: P20MD006737]; PIs, Quinn and Thomas).